| 000 | 01795 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518071209.0 | ||
| 264 | 0 | _c20200603 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2019.109655 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Jie | |
| 245 | 0 | 0 |
_aUncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validation. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cJan 2020 |
||
| 300 |
_a109655 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoprotein A-I _xmetabolism |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 |
_aComplement C3 _xmetabolism |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aDrugs, Chinese Herbal _xpharmacology |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aInterleukin-16 _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aZhang, Yun | |
| 700 | 1 | _aLiu, Yong-Mei | |
| 700 | 1 | _aYang, Xiao-Chen | |
| 700 | 1 | _aChen, Yin-Ying | |
| 700 | 1 | _aWu, Guang-Jun | |
| 700 | 1 | _aHe, Xuan-Hui | |
| 700 | 1 | _aDuan, Lian | |
| 700 | 1 | _aDong, Yan | |
| 700 | 1 | _aMa, Ru-Feng | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 121 _gp. 109655 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2019.109655 _zAvailable from publisher's website |
| 999 |
_c30320198 _d30320198 |
||